---
title: "Max Healthcare Institute Ltd (MAXHEALTH) — Share Price, Financials & Analysis"
symbol: "MAXHEALTH"
company: "Max Healthcare Institute Ltd"
canonical: "https://tapetide.com/stocks/MAXHEALTH"
isin: "INE027H01010"
nse_symbol: "MAXHEALTH"
bse_code: "543220"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 99952.14
generated_at: "2026-09-13T19:40:04.643Z"
---

# Max Healthcare Institute Ltd (MAXHEALTH)

Canonical page: https://tapetide.com/stocks/MAXHEALTH

## Company

- **NSE Symbol:** MAXHEALTH
- **BSE Code:** 543220
- **ISIN:** INE027H01010
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2020-08-21
- **Face Value:** ₹10
- **F&O Eligible:** Yes
- **Website:** maxhealthcare.in

## About

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]

## Latest Price

- **Price:** ₹1037.7
- **Change:** -0.9 (-0.09%)
- **Open:** ₹1028.2
- **Day High:** ₹1041.5
- **Day Low:** ₹1022.7
- **Previous Close:** ₹1038.6
- **Volume:** 2506618
- **As Of:** 2026-09-11T10:21:25+00:00

## Key Fundamentals

Observed at 2026-09-11T04:33:49.432033Z.

- **Market Cap:** ₹99952.14 Cr
- **Classification:** Midcap
- **P/E (reported):** 69.4
- **P/E (TTM):** 69.27
- **EPS (TTM):** ₹14.98
- **EPS (reported):** ₹10.84
- **Book Value:** ₹110.39
- **Price to Book:** 9.41
- **Dividend Yield:** 0.19%
- **ROE:** 13.42%
- **ROCE:** 12.7%
- **Debt to Equity:** 0.32
- **Revenue (yearly):** ₹8536.1 Cr
- **Net Income:** ₹1442.4 Cr
- **EBITDA:** ₹2405.5 Cr
- **52-Week High:** ₹1221.9
- **52-Week Low:** ₹903
- **RSI (14):** 54.59

## Tapetide Score

- **Score:** 39 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 12 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 43.19 | 9% |
| growth | 44.19 | 9% |
| momentum | 12 | 12% |
| ownership | 49.65 | 24% |
| quality | 47.07 | 22% |
| valuation | 30.28 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 9.40 times its book value
- Tax rate seems low
- Company has a low return on equity of 13.7% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 13.6% of profits over last 3 years

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 13.59% | 45.62% | 120.56% |
| ebitda margin growth | -2.34% | 1% | -5.82% | 6.9% |
| net income growth | -5.61% | 34.06% | 10% | 60% |
| revenue growth | 9.86% | 18.82% | 22% | 27% |
| roce | -4.5% | 8.36% | -4.22% | 12.06% |
| roe | -5.63% | 17% | 12.49% | 39.36% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1363 | 1335 | 1423 | 1543 | 1707 | 1868 | 1910 | 2028 | 2135 | 2068 | 2143 | 2366 |
| Expenses | 976 | 949 | 1041 | 1156 | 1257 | 1369 | 1398 | 1505 | 1560 | 1529 | 1536 | 1768 |
| Operating Profit | 387 | 386 | 382 | 387 | 451 | 499 | 512 | 523 | 575 | 538 | 606 | 598 |
| OPM % | 28 | 29 | 27 | 25 | 26 | 27 | 27 | 26 | 27 | 26 | 28 | 25 |
| Other Income | 45 | 46 | 45 | 35 | 41 | -40 | 47 | 37 | 33 | -3 | 48 | 41 |
| Interest | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 | 54 | 60 | 67 | 71 |
| Depreciation | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 | 108 | 111 | 123 | 132 |
| Profit before tax | 366 | 360 | 336 | 321 | 374 | 309 | 402 | 400 | 446 | 365 | 465 | 436 |
| Tax % | 24 | 20 | 25 | 26 | 25 | 23 | 21 | 23 | -10 | 17 | 26 | 26 |
| Net Profit | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 | 491 | 301 | 342 | 323 |
| EPS in Rs | 2.85 | 2.98 | 2.59 | 2.43 | 2.9 | 2.46 | 3.28 | 3.17 | 5.05 | 3.09 | 3.52 | 3.32 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1729 | 1691 | 1059 | 2508 | 3937 | 4563 | 5406 | 7028 | 8373 | 8712 |
| Expenses | 1616 | 1535 | 965 | 2101 | 2986 | 3322 | 3913 | 5180 | 6131 | 6394 |
| Operating Profit | 113 | 156 | 94 | 407 | 951 | 1241 | 1493 | 1849 | 2243 | 2318 |
| OPM % | 7 | 9 | 9 | 16 | 24 | 27 | 28 | 26 | 27 | 27 |
| Other Income | 65 | 56 | 48 | -122 | 110 | 139 | 177 | 82 | 114 | 118 |
| Interest | 99 | 101 | 83 | 179 | 101 | 84 | 60 | 165 | 235 | 251 |
| Depreciation | 94 | 103 | 46 | 174 | 221 | 232 | 245 | 359 | 447 | 474 |
| Profit before tax | -15 | 8 | 13 | -69 | 739 | 1064 | 1365 | 1406 | 1676 | 1711 |
| Tax % | 65 | 102 | -1 | 67 | 18 | -4 | 23 | 24 | 14 | — |
| Net Profit | -25 | 0 | 59 | -138 | 605 | 1104 | 1058 | 1076 | 1442 | 1457 |
| EPS in Rs | -0.47 | -0.06 | 1.1 | -1.42 | 6.24 | 11.37 | 10.88 | 11.07 | 14.82 | 14.98 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 9 | 14 | 14 | 13 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 | 973 |
| Reserves | 655 | 627 | 426 | 2016 | 4673 | 5313 | 6439 | 7436 | 8409 | 9774 |
| Borrowings | 874 | 981 | 1003 | 875 | 1101 | 913 | 689 | 1299 | 3010 | 3478 |
| Other Liabilities | 1080 | 1157 | 1389 | 546 | 1803 | 1993 | 2003 | 2293 | 2795 | 2959 |
| Total Liabilities | 3146 | 3302 | 3355 | 3974 | 8543 | 9189 | 10102 | 12000 | 15186 | 17184 |
| Fixed Assets | 2244 | 2227 | 2192 | 851 | 6536 | 7018 | 7039 | 8784 | 11502 | 12991 |
| CWIP | 46 | 38 | 87 | 28 | 27 | 151 | 252 | 553 | 901 | 593 |
| Investments | 0 | 0 | 1 | 2182 | 1 | 1 | 1 | 2 | 3 | 5 |
| Other Assets | 856 | 1036 | 1075 | 913 | 1980 | 2020 | 2810 | 2661 | 2781 | 3595 |
| Total Assets | 3146 | 3302 | 3355 | 3974 | 8543 | 9189 | 10102 | 12000 | 15186 | 17184 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 156 | 166 | 89 | 77 | 118 | 741 | 1209 | 1122 | 1438 | 1633 |
| Cash from Investing Activity | -104 | -124 | -17 | -2641 | 206 | -764 | -1187 | -1253 | -1593 | -1688 |
| Cash from Financing Activity | -48 | -48 | -74 | 2353 | 191 | -294 | -289 | -264 | -163 | 59 |
| Net Cash Flow | 4 | -6 | -2 | -210 | 516 | -317 | -266 | -395 | -318 | 4 |
| Free Cash Flow | 41 | 100 | -27 | -13 | 1 | 192 | 877 | 342 | 500 | 165 |
| CFO/OP | 135 | 166 | 75 | 89 | 15 | 89 | 110 | 93 | 95 | 89 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 53 | 59 | 78 | 33 | 53 | 36 | 27 | 31 | 36 | 42 |
| Inventory Days | 20 | 24 | 26 | 43 | 34 | 24 | 30 | 26 | 26 | 23 |
| Days Payable | 184 | 227 | 292 | 286 | 274 | 174 | 212 | 207 | 198 | 175 |
| Cash Conversion Cycle | -111 | -144 | -188 | -210 | -187 | -114 | -155 | -149 | -136 | -110 |
| Working Capital Days | -12 | -24 | -152 | -137 | -44 | -24 | -46 | -43 | -46 | -41 |
| ROCE % | — | 4 | 6 | 4 | 7 | 12 | 15 | 16 | 15 | 15 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 23.76% | 23.75% | 23.75% | 23.74% | 23.74% | 23.74% | 23.74% | 23.74% | 23.74% | 23.72% | 23.71% | 23.71% |
| FIIs | 60.39% | 60.69% | 57.33% | 56.98% | 57.29% | 56.93% | 54.74% | 54.76% | 51.8% | 50.55% | 45.39% | 41.78% |
| DIIs | 11.32% | 11.34% | 14.96% | 15.36% | 15.14% | 15.55% | 17.58% | 17.42% | 20.03% | 21.2% | 26.32% | 29.96% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 3.55% | 3.34% | 3.29% | 3.24% | 3.18% | 3.13% | 3.31% | 3.42% | 3.08% | 3.13% | 3.27% | 3.22% |
| Others | 0.98% | 0.88% | 0.67% | 0.67% | 0.65% | 0.64% | 0.63% | 0.66% | 1.35% | 1.38% | 1.31% | 1.33% |
| No. of Shareholders | 118635 | 111338 | 127009 | 136254 | 137856 | 140028 | 151633 | 162119 | 180891 | 203837 | 216996 | 224606 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 7 / 4 / 8

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1011.76 | Buy |
| EMA (10) | 1017.22 | Buy |
| SMA (20) | 1008.26 | Buy |
| EMA (20) | 1019.27 | Buy |
| SMA (50) | 1054.82 | Sell |
| EMA (50) | 1036.01 | Buy |
| SMA (100) | 1044.56 | Sell |
| EMA (100) | 1042.52 | Sell |
| SMA (200) | 1039.79 | Sell |
| EMA (200) | 1054.91 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 54.29 | Neutral |
| MACD (12,26,9) | -7.2 | Buy |
| Stochastic (14,3,3) | 93.88 | Sell |
| ADX (14) | 21.02 | Neutral |
| Williams %R (14) | -6.46 | Sell |
| ATR (14) | 24.73 | Neutral |
| ROC (12) | 3.25 | Buy |
| Stoch RSI (14) | 98.25 | Sell |
| UO (7,14,28) | 69.78 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 19 | 76% |
| Hold | 2 | 8% |
| Sell | 4 | 16% |

Based on 25 analyst ratings, observed at 2026-09-11T04:33:49.471658+00:00.

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Max Healthcare to acquire 58.4% stake in Kalinga Hospital for ₹300 crore; approves ₹100 crore loan and ₹300 crore ECB. | [Announcement under Regulation 30 (LODR)-Acquisition 8 Apr - Max Healthcare to acquire 58.4% stake in Kalinga Hospital for ₹300 crore; approves ₹100 crore loan and ₹300 crore ECB.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/111853df-c202-4ed9-9cb3-ed94e28f0854.pdf) |
| 8 Apr - Board approves 58.4% acquisition of Kalinga Hospital for ₹300 crore, plus ₹100 crore loan and ₹300 crore ECB. | [Announcement under Regulation 30 (LODR)-Change in Directorate 8 Apr - Board approves 58.4% acquisition of Kalinga Hospital for ₹300 crore, plus ₹100 crore loan and ₹300 crore ECB.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1542d143-8c91-4988-b965-e3519dc9f497.pdf) |
| 8 Apr - Board approved 58.4% stake acquisition in Kalinga Hospital for ₹300 crore, plus ₹100 crore loan and ₹300 crore ECB. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 8 Apr - Board approved 58.4% stake acquisition in Kalinga Hospital for ₹300 crore, plus ₹100 crore loan and ₹300 crore ECB.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e4fc1a71-65cd-4ebc-b5b0-5646a05ab309.pdf) |
| 5h - Regulation 74(5) certificate confirms no demat requests during quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5h - Regulation 74(5) certificate confirms no demat requests during quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/6d14c79e-2d01-4fe2-b0e3-9954c64462be.pdf) |
| 4h - GST Officer withdrew ₹55.20 crore demand against Max Healthcare on April 21, 2026. | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 4h - GST Officer withdrew ₹55.20 crore demand against Max Healthcare on April 21, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/14db4b39-db03-40c6-9da6-df96ae8cbe5d.pdf) |
| 25 Mar - NCLT ordered dissolution of ET Planners on March 25, 2026; liquidation completed; no material financial impact. | [Hon'Ble National Company Law Tribunal Order For Voluntary Liquidation Of ET Planners Private Limited 25 Mar - NCLT ordered dissolution of ET Planners on March 25, 2026; liquidation completed; no material financial impact.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/61375384-cff1-4eed-a302-138851068ae1.pdf) |
| 24 May - Max Healthcare applied on May 24, 2026 for RLCHF reclassification from promoter group to public. | [Update On Re-Classification Of Radiant Life Care Hospital Foundation From Promoter Group To Public Category 24 May - Max Healthcare applied on May 24, 2026 for RLCHF reclassification from promoter group to public.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94b4ab79-2592-40bc-947d-229e59597321.pdf) |
| 23h - Max Healthcare to acquire 58.4% of Kalinga Hospital for ₹300 crore, with ₹100 crore loan and ₹300 crore ECB. | [Outcome Of Board Meeting 23h - Max Healthcare to acquire 58.4% of Kalinga Hospital for ₹300 crore, with ₹100 crore loan and ₹300 crore ECB.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/903989c0-84cd-45ff-a25e-29ab4c1366ad.pdf) |
| 21 Feb - Appeal partly allowed: revised GST ₹85.36 lakh, penalty ₹85.36 lakh, interest ₹6.89 lakh; received 20 Feb 2026. | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 21 Feb - Appeal partly allowed: revised GST ₹85.36 lakh, penalty ₹85.36 lakh, interest ₹6.89 lakh; received 20 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/54ce74ce-e489-4df5-a02c-18b2c49f423e.pdf) |
| 21 Apr - GST Officer withdrew ₹55.20 crore demand against Max Healthcare on April 21, 2026. | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 21 Apr - GST Officer withdrew ₹55.20 crore demand against Max Healthcare on April 21, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/14db4b39-db03-40c6-9da6-df96ae8cbe5d.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Updates on Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc0f7b3e-1ef1-47b5-a62d-e823b14fd04a.pdf) |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74a1ee85-e5fa-4f73-a5e5-b7c09b3ef476.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=492cf69f-6ec4-44a3-93e5-d86bdf95d694.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78edfeb9-1539-48a3-a434-c2e09089cec1.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88cd0f22-74af-40e7-bcd9-b135e6f9c9bf.pdf) |
| 2026-08-26 | [Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bece10eb-8b13-4b48-a4e8-0edc106f6790.pdf) |
| 2026-08-19 | [Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6581f454-5127-4299-a525-ee13951e46a5.pdf) |
| 2026-08-14 | [Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99e30e60-c240-4c9f-95c5-93bc511c00f5.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e08d33d-b401-40d3-b317-d9a3923d38d1.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Meeting Held On August 13 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d432055-c3e2-4c92-800e-c4625c918fb9.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=922086cc-1e96-40b8-966b-547204ed8364.pdf) |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32d9c73a-07ea-42f8-bffa-14ed214222b7.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b765c0b2-67cc-4aea-91e7-7bffcbeff79b.pdf) |
| 2025-11-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a905df4-c8df-4945-8494-e060944ce284.pdf) |
| 2025-08-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27ca5acb-a339-4512-a857-08805d78d44a.pdf) |
| 2025-05-27 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dc534c3-fec8-4f80-bd0b-94cfa5ff84a9.pdf) |
| 2025-02-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=772196e9-ad6f-4e82-acb4-b4394c8771dc.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c29afa3-67e6-46b6-abe3-34a0eab84d26.pdf) |
| 2024-08-08 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b38d88aa-d7b4-4f6b-9827-3e00b2d06515.pdf) |
| 2024-05-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a61b15e-210a-4220-b0c9-c179f35ba999.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43563b7c-0f62-4589-aab6-e255dcf68635.pdf) |
| 2026-05-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49477928-7f1d-4f60-a0b8-0b5f70111e4d.pdf) |
| 2026-02-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed5af43a-ff90-4f5d-a97d-838a61e86fb5.pdf) |
| 2026-02-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3dac3a4d-dd64-4107-b1d9-00978230d033.pdf) |
| 2025-11-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d5ec090-6da3-4749-b0a9-1d953cef653c.pdf) |
| 2025-11-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cee54dc0-5625-40af-b4d9-1e7ebafcf7dd.pdf) |
| 2025-08-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7c00969-35a2-4639-bf42-fbb85d27a7bd.pdf) |
| 2025-05-31 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0c60b6e-0c90-4917-b0b8-d1cd46715157.pdf) |
| 2025-02-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f4e03fa-2ab1-4af1-a266-5678ffc2d2ef.pdf) |
| 2024-11-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74fba06b-d591-4900-8757-b226bdd61cbe.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-14 | [Audio Recording Of Earnings Call Held On August 14 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3bee59c-fddb-4fe0-a6c5-e3be03a8035c.pdf) |
| 2026-05-22 | [Audio Recording Of Earnings Call Held On May 22 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d64ac8-994f-4c38-8fca-1bccf296c0cd.pdf) |
| 2026-02-06 | [Audio Recording Of Earnings Call Held On February 6 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcb6faa0-57cc-42ca-8c0c-3097e8c84942.pdf) |
| 2025-11-17 | [Audio Recording Of Earnings Call Held On November 17 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6576c5c-0dc6-4d1c-8393-db2dd1b921a4.pdf) |
| 2025-08-14 | [Audio Recording Of Earnings Call Held On August 14 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75981eb5-8b39-4353-b497-cd9aafed131b.pdf) |
| 2025-05-21 | [Audio Recording Of Earnings Call Held On May 21 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f04bb1c-927d-465a-bc10-b97cc49b24a9.pdf) |
| 2025-01-31 | [Audio Recording Of Earnings Call Held On January 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17273407-f1e6-4eaa-bcc4-d7139a65993c.pdf) |
| 2024-11-07 | [Audio Recording Of Earnings Call Held On November 7, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94868084-b1d5-4067-8b1b-16b17f3247d2.pdf) |
| 2024-08-02 | [Audio Recording Of Earnings Call Held On August 2, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94ad7092-ebdb-443d-85c6-47b9c1ea45c7.pdf) |
| 2024-05-23 | [Audio Recording Of Earnings Call Held On May 23, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67c605a1-20a1-4016-b842-a5fa1b67ba68.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Results - Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac292e7a-d427-49ee-ae8c-0b0acd9da921.pdf) |
| 2026-05-21 | [Results For Fourth Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd4bf562-4290-439c-81dd-d7ac2aeca9d3.pdf) |
| 2026-02-05 | [Results - Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6a8dcfb-d00e-468f-b47e-7a976a763e97.pdf) |
| 2025-11-14 | [Results - Financial Results For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5995bf1c-4b40-495a-a6fe-511dca21e3f8.pdf) |
| 2025-08-13 | [Results - Financial Results For Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77b28dfd-7afd-44d1-8a60-1b08c4600961.pdf) |
| 2025-05-20 | [Results For Quarter And Financial Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25e68d79-9b33-4c9a-af85-1dcbd6076786.pdf) |
| 2025-01-30 | [Results- Financial Results For Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63f3a5da-2f85-4ad4-bb26-af329db02912.pdf) |
| 2024-11-05 | [Results - Financial Results For Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5245cd4-d89f-45d6-9e57-19e9704f3800.pdf) |
| 2024-08-01 | [Results - Financial Results For Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=021df355-f694-467f-b591-2dd6ae888a14.pdf) |
| 2024-05-22 | [Results- Financial Results For Quarter And Financial Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a22a199a-8fd8-4c12-817e-0054fcf9df0f.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=beb93c9e-e9b6-4b79-be5f-a83dde0943a9.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/beb93c9e-e9b6-4b79-be5f-a83dde0943a9.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cee54dc0-5625-40af-b4d9-1e7ebafcf7dd.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7a905df4-c8df-4945-8494-e060944ce284.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=705ed26d-c89d-4a3f-8b32-5d655a8583fc.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/705ed26d-c89d-4a3f-8b32-5d655a8583fc.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c29afa3-67e6-46b6-abe3-34a0eab84d26.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/32d9c73a-07ea-42f8-bffa-14ed214222b7.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/32d9c73a-07ea-42f8-bffa-14ed214222b7.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/49477928-7f1d-4f60-a0b8-0b5f70111e4d.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ff687278-4b63-403b-ab82-e9ae0259eead.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/da4ae2d4-5de6-4ad5-8d07-0d20a2f16f5e.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:40:04.643Z.